Elutia Shares Dip 2.78% to $0.84 – Still Up 0.96% vs Peers, Holding $37M Cap
Elutia Inc. shares slipped 2.78 % to $0.84, yet remain 0.96 % above the prior month and near a 200‑day trend of $0.97 – a biotech option worth watching.
2 minutes to read
ELUTIA INC
Elutia Inc. (ELUT) Hits 1.48% Gain, Nearing 52‑Week Low Despite Small‑Cap Biotech Upside
Elutia Inc. (ELUT) trades near its 200‑day average, offering biotech investors a small‑cap play with a drug‑eluting platform that may be undervalued compared to its 52‑week range.
2 minutes to read
Elutia Inc. Rises 1.48% to $0.82, Supported by 200‑Day SMA and Positive Market Sentiment
Elutia Inc. (ELUT) rises 1.48% to $0.82, driven by solid technical support, growing biotech optimism, and upcoming regulatory milestones for its drug‑eluting platform.
3 minutes to read
Elutia Inc. (ELUT) Shares Rise 2.64% as Biotech Market Grows
Explore Elutia Inc.’s latest stock movement, market metrics, and biotech focus—discover why investors are watching this Nasdaq‑listed drug‑eluting company.
2 minutes to read